Rodrigo E. Mendes mostly deals with Microbiology, Staphylococcus aureus, Broth microdilution, Linezolid and 23S ribosomal RNA. His study looks at the relationship between Microbiology and topics such as Klebsiella pneumoniae, which overlap with Enterobacteriaceae. His Staphylococcus aureus research is multidisciplinary, incorporating elements of Enterococcus faecium and Antibiotic resistance.
His Broth microdilution research includes elements of Viridans streptococci, Acinetobacter, Pseudomonas aeruginosa, Ceftazidime and Meropenem. His work deals with themes such as Tigecycline, Staphylococcus epidermidis and Potency, which intersect with Linezolid. The study incorporates disciplines such as Amikacin, Vancomycin and Levofloxacin in addition to Tigecycline.
Rodrigo E. Mendes mainly focuses on Microbiology, Staphylococcus aureus, Linezolid, Broth microdilution and Antimicrobial. Rodrigo E. Mendes works in the field of Microbiology, focusing on Streptococcus pneumoniae in particular. His Staphylococcus aureus study incorporates themes from In vitro and Drug resistance.
His biological study spans a wide range of topics, including Enterococcus, Daptomycin, Teicoplanin and Staphylococcus epidermidis. His study in Broth microdilution is interdisciplinary in nature, drawing from both Tigecycline, Antibacterial agent and Meropenem. The various areas that Rodrigo E. Mendes examines in his Antimicrobial study include Cephalosporin, Levofloxacin, Antibiotic resistance and Escherichia coli.
Microbiology, Antimicrobial, Staphylococcus aureus, Broth microdilution and Sentry are his primary areas of study. His biological study focuses on Meropenem. His Antimicrobial research is multidisciplinary, relying on both Infective endocarditis, Lipoglycopeptide, Staphylococcus saprophyticus, Cephalosporin and Antibiotic resistance.
The Staphylococcus aureus study combines topics in areas such as Clindamycin, In vitro and Streptococcus pneumoniae. His Sentry research incorporates themes from Antimicrobial susceptibility and Pathogen. His studies in Linezolid integrate themes in fields like Enterococcus and Teicoplanin.
Rodrigo E. Mendes mainly investigates Microbiology, Broth microdilution, Sentry, Antimicrobial and Staphylococcus aureus. His Microbiology research is multidisciplinary, incorporating perspectives in Pseudomonas aeruginosa, Klebsiella pneumoniae and Enterobacteriaceae. His Sentry study combines topics in areas such as Streptococcus pneumoniae and Public health.
His research investigates the connection with Antimicrobial and areas like Antibiotic resistance which intersect with concerns in Drug development, Infection control and Clinical trial. When carried out as part of a general Staphylococcus aureus research project, his work on Methicillin-resistant Staphylococcus aureus is frequently linked to work in In vitro diagnostic, therefore connecting diverse disciplines of study. His research integrates issues of Enterococcus faecalis and Enterococcus faecium in his study of Vancomycin.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Early Dissemination of NDM-1- and OXA-181-Producing Enterobacteriaceae in Indian Hospitals: Report from the SENTRY Antimicrobial Surveillance Program, 2006-2007
Mariana Castanheira;Lalitagauri M. Deshpande;Dilip Mathai;Jan M. Bell.
Antimicrobial Agents and Chemotherapy (2011)
First Report of cfr-Mediated Resistance to Linezolid in Human Staphylococcal Clinical Isolates Recovered in the United States
Rodrigo E. Mendes;Lalitagauri M. Deshpande;Mariana Castanheira;Joseph DiPersio.
Antimicrobial Agents and Chemotherapy (2008)
Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY Antimicrobial Surveillance Program.
Helio S. Sader;Ana C. Gales;Michael A. Pfaller;Rodrigo E. Mendes.
Brazilian Journal of Infectious Diseases (2001)
Linezolid update: Stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms
Rodrigo E. Mendes;Lalitagauri M. Deshpande;Ronald N. Jones.
Drug Resistance Updates (2014)
Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program.
Rodrigo E Mendes;Jan M Bell;John D Turnidge;John D Turnidge;Mariana Castanheira.
Journal of Antimicrobial Chemotherapy (2008)
Metallo-beta-lactamase detection: comparative evaluation of double-disk synergy versus combined disk tests for IMP-, GIM-, SIM-, SPM-, or VIM-producing isolates.
Renata C. Picão;Soraya S. Andrade;Adriana Gianinni Nicoletti;Eloiza H. Campana.
Journal of Clinical Microbiology (2008)
Transferable Plasmid-Mediated Resistance to Linezolid Due to cfr in a Human Clinical Isolate of Enterococcus faecalis
Lorena Diaz;Pattarachai Kiratisin;Rodrigo E. Mendes;Diana Panesso;Diana Panesso.
Antimicrobial Agents and Chemotherapy (2012)
Meropenem-Vaborbactam Tested against Contemporary Gram-Negative Isolates Collected Worldwide during 2014, Including Carbapenem-Resistant, KPC-Producing, Multidrug-Resistant, and Extensively Drug-Resistant Enterobacteriaceae.
Mariana Castanheira;Michael D. Huband;Rodrigo E. Mendes;Robert K. Flamm.
Antimicrobial Agents and Chemotherapy (2017)
Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, Italy
Rodrigo E. Mendes;Lalitagauri M. Deshpande;David J. Farrell;Teresa Spanu.
Journal of Antimicrobial Chemotherapy (2010)
Detection of a New cfr-Like Gene, cfr(B), in Enterococcus faecium Isolates Recovered from Human Specimens in the United States as Part of the SENTRY Antimicrobial Surveillance Program.
Lalitagauri M. Deshpande;Deborah S. Ashcraft;Heather P. Kahn;George Pankey.
Antimicrobial Agents and Chemotherapy (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: